Nagaileben Co., Ltd.

TSE:7447 Stock Report

Market Cap: JP¥69.2b

Nagaileben Past Earnings Performance

Past criteria checks 1/6

Nagaileben's earnings have been declining at an average annual rate of -4%, while the Medical Equipment industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 0.5% per year. Nagaileben's return on equity is 6.8%, and it has net margins of 16.7%.

Key information

-4.0%

Earnings growth rate

-3.2%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate-0.5%
Return on equity6.8%
Net Margin16.7%
Last Earnings Update30 Nov 2024

Recent past performance updates

Recent updates

Nagaileben (TSE:7447) Has Affirmed Its Dividend Of ¥60.00

Aug 06
Nagaileben (TSE:7447) Has Affirmed Its Dividend Of ¥60.00

Nagaileben (TSE:7447) Has Announced A Dividend Of ¥60.00

Jul 22
Nagaileben (TSE:7447) Has Announced A Dividend Of ¥60.00

Nagaileben (TSE:7447) Has Affirmed Its Dividend Of ¥60.00

Jun 19
Nagaileben (TSE:7447) Has Affirmed Its Dividend Of ¥60.00

Nagaileben (TSE:7447) Is Paying Out A Dividend Of ¥60.00

Jun 05
Nagaileben (TSE:7447) Is Paying Out A Dividend Of ¥60.00

Nagaileben's (TSE:7447) Dividend Will Be ¥60.00

May 21
Nagaileben's (TSE:7447) Dividend Will Be ¥60.00

Nagaileben (TSE:7447) Is Due To Pay A Dividend Of ¥60.00

Apr 25
Nagaileben (TSE:7447) Is Due To Pay A Dividend Of ¥60.00

Nagaileben's (TSE:7447) Dividend Will Be ¥60.00

Apr 04
Nagaileben's (TSE:7447) Dividend Will Be ¥60.00

Revenue & Expenses Breakdown

How Nagaileben makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:7447 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Nov 2416,5742,7712,7860
31 Aug 2416,4122,8222,7700
31 May 2416,6402,9412,7670
29 Feb 2416,6423,0602,7150
30 Nov 2317,2753,2452,7220
31 Aug 2317,1813,2262,6730
31 May 2317,3153,2562,6450
28 Feb 2317,8593,6402,6430
30 Nov 2217,3213,5752,5710
31 Aug 2217,7453,7782,5550
31 May 2217,1463,6402,5150
28 Feb 2217,3113,4852,5360
30 Nov 2117,3463,5692,5070
31 Aug 2117,5633,6472,5220
31 May 2118,8104,0572,4780
28 Feb 2118,0843,8332,4570
30 Nov 2017,7753,7232,5060
31 Aug 2017,0663,4742,5380
31 May 2016,1593,2222,5640
29 Feb 2016,6033,4182,5360
30 Nov 1916,7613,4752,5180
31 Aug 1916,7853,4452,5890
31 May 1916,5833,3772,5770
28 Feb 1916,9583,5272,5660
30 Nov 1816,9863,5512,5490
31 Aug 1817,1443,6752,4530
31 May 1817,0453,6062,4930
28 Feb 1817,2873,7042,4860
30 Nov 1717,2233,7172,4960
31 Aug 1717,0173,6732,4960
31 May 1717,1073,7132,4540
28 Feb 1716,7483,5192,4530
30 Nov 1616,8203,4202,4440
31 Aug 1616,5373,2622,4440
31 May 1616,5053,2082,4640
29 Feb 1616,2483,0462,4440
30 Nov 1515,7352,9452,3920
31 Aug 1516,1503,2252,3700
31 May 1515,6553,1102,3680
28 Feb 1516,2793,2622,3870
30 Nov 1416,0073,2572,3750
31 Aug 1416,2143,2242,3340
31 May 1416,2752,9562,3810
28 Feb 1415,9373,0622,3220

Quality Earnings: 7447 has high quality earnings.

Growing Profit Margin: 7447's current net profit margins (16.7%) are lower than last year (18.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 7447's earnings have declined by 4% per year over the past 5 years.

Accelerating Growth: 7447's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 7447 had negative earnings growth (-14.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.6%).

Return on Equity

High ROE: 7447's Return on Equity (6.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 05:38
End of Day Share Price 2024/12/30 00:00
Earnings2024/11/30
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nagaileben Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.
Hidemaru YamaguchiCitigroup Inc
Masatoshi NagataIchiyoshi Research Institute Inc.